Safety and efficacy of Sildenafil therapy in children with pulmonary hypertension
- 20 April 2005
- journal article
- clinical trial
- Published by Elsevier in International Journal of Cardiology
- Vol. 100 (2) , 267-273
- https://doi.org/10.1016/j.ijcard.2004.09.002
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Bosentan treatment in patients with primary pulmonary hypertension receiving nonparenteral prostanoidsEuropean Respiratory Journal, 2003
- Reversal of shunting in pulmonary hypertension after treatment with oral SildenafilCardiology in the Young, 2002
- Pharmacokinetics of sildenafil after single oral doses in healthy male subjects: absolute bioavailability, food effects and dose proportionalityBritish Journal of Clinical Pharmacology, 2002
- Long term treatment of pulmonary arterial hypertension with beraprost, an oral prostacyclin analogueHeart, 2001
- SildenafilDrugs, 1999
- A six-minute walk test for assessing exercise tolerance in severely ill childrenThe Journal of Pediatrics, 1996
- Comparison of Doppler derived haemodynamic variables and simultaneous high fidelity pressure measurements in severe pulmonary hypertension.Heart, 1994
- Profile of paediatric patients with pulmonary hypertension judged by responsiveness to vasodilators.Heart, 1993
- Lung biopsy findings in transposition of the great arteries with ventricular septal defect: Potentially reversible pulmonary vascular disease is not always synonymous with operabilityJournal of the American College of Cardiology, 1987
- Effect of long term oxygen treatment at home in children with pulmonary vascular disease.Heart, 1986